Background: Dysregulation of metabolic regulatory hormones often occurs during the progress of obesity. Key regulatory hormone insulin-growth hormone (GH) balance has recently been proposed to maintain metabolism profiles. Time-restricted feeding (TRF) is an effective strategy against obesity without detailed research on pulsatile GH releasing patterns. Methods: TRF was performed in an over-eating melanocortin 4 receptor-knockout (MC4RKO) obese mouse model using normal food. Body weight and food intake were measured. Series of blood samples were collected for 6-h pulsatile GH profile, glucose tolerance test, and insulin tolerance test at 5, 8, and 9 weeks of TRF, respectively. Indirect calorimetric recordings were performed by the Phenomast...
Disruption of the growth hormone (GH) axis promotes longevity and delays aging. In contrast, GH over...
Disruption of the growth hormone (GH) axis promotes longevity and delays aging. In contrast, GH over...
Objective: The melanin‐concentrating hormone (MCH) is a centrally acting peptide implicated in the ...
BackgroundMenopause is associated with significant hormonal changes that result in increased total b...
SummaryWhile diet-induced obesity has been exclusively attributed to increased caloric intake from f...
SummaryBecause current therapeutics for obesity are limited and only offer modest improvements, nove...
Time-restricted feeding (TRF) is known to be an effective strategy for weight loss and metabolic hea...
Background: Time restricted feeding (TRF) refers to dietary interventions in which food access is li...
Studies suggest that time-restricted feeding (TRF) may prevent obesity and its commodities. At prese...
The well-balanced secretion between insulin and growth hormone (GH) is essential in regulating subst...
Background: Insulin and growth hormone (GH) - 2 vital metabolic regulatory hormones - regulate gluco...
Growth hormone (GH) inhibits fat accumulation and promotes protein accretion, therefore the fall in ...
Therapeutic benefits of caloric restriction (CR) on clinical outcomes in the treatment of neurodegen...
Accumulating evidence indicates that obesity with its associated metabolic dysregulation, including ...
Aging is a natural part of an organism’s life cycle. It is, however, associated with increased risks...
Disruption of the growth hormone (GH) axis promotes longevity and delays aging. In contrast, GH over...
Disruption of the growth hormone (GH) axis promotes longevity and delays aging. In contrast, GH over...
Objective: The melanin‐concentrating hormone (MCH) is a centrally acting peptide implicated in the ...
BackgroundMenopause is associated with significant hormonal changes that result in increased total b...
SummaryWhile diet-induced obesity has been exclusively attributed to increased caloric intake from f...
SummaryBecause current therapeutics for obesity are limited and only offer modest improvements, nove...
Time-restricted feeding (TRF) is known to be an effective strategy for weight loss and metabolic hea...
Background: Time restricted feeding (TRF) refers to dietary interventions in which food access is li...
Studies suggest that time-restricted feeding (TRF) may prevent obesity and its commodities. At prese...
The well-balanced secretion between insulin and growth hormone (GH) is essential in regulating subst...
Background: Insulin and growth hormone (GH) - 2 vital metabolic regulatory hormones - regulate gluco...
Growth hormone (GH) inhibits fat accumulation and promotes protein accretion, therefore the fall in ...
Therapeutic benefits of caloric restriction (CR) on clinical outcomes in the treatment of neurodegen...
Accumulating evidence indicates that obesity with its associated metabolic dysregulation, including ...
Aging is a natural part of an organism’s life cycle. It is, however, associated with increased risks...
Disruption of the growth hormone (GH) axis promotes longevity and delays aging. In contrast, GH over...
Disruption of the growth hormone (GH) axis promotes longevity and delays aging. In contrast, GH over...
Objective: The melanin‐concentrating hormone (MCH) is a centrally acting peptide implicated in the ...